Mr. Cohen has been President of The Walden Group for more than 25 years and has orchestrated more than 200 merger, acquisition and corporate alliance transactions there. He is an expert on healthcare industry dynamics, corporate valuation matters, and complex transactions and corporate growth strategies. Frequently, Mr. Cohen is called upon to…

Mr. Cohen graduated from Northwestern University with a BA and has an MBA from Babson College’s F.W. Olin Graduate School of Business.  He is an experienced merger & acquisition professional who has worked for The Walden Group, MMG Advisors (consumer products and retail investment banking), and Mentor Capital, a Boston-based private equity firm.

Ms. Wu received a Bachelor or Financial Engineering and Accounting from the University of International Business and Economics (Beijing) and a Masters of Science in Business Analytics from Bentley University (Waltham, MA).  She has significant experience in mergers and acquisitions, financial analytics and healthcare market research and analysis, having worked for PricewaterhouseCoopers Consultants (Shanghai), The Walden Group and other firms conducting strategic transactional work.

Ms. Kenneally has years of experience working in healthcare mergers and acquisitions; healthcare market. clinical and company research; financial analytics; government auditing; accounting; and budgeting, among other areas. Her diverse experience includes prestigious roles in local government, including serving as a Deputy Village Treasurer at Briarcliff Manor, NY. She holds a bachelor’s degree in Agricultural Economics with a major in Finance and Cooperatives from the University of the Philippines, and an MBA from the University of Phoenix. Besides working for years at The Walden Group, Ms. Kenneally has also worked at New York Medical College, State Street Bank, Deutsche Bank, and other firms specializing in strategic transactional work.

Matt Riley is an accomplished medical device product launch and management specialist, with significant experience in peripheral arterial disease, venous disease, and blood/laboratory testing. His medical device expertise includes those addressing atherectomy, thrombectomy, angioplasty, drug-coated balloons, stents, filters, CTO crossing, lytic delivery and other clinical areas.  Mr. Riley developed his skill sets at Becton Dickinson and C.R. Bard, where he served in Marketing and Senior Product Managerial roles. Before that, he served as Senior Manager (Captain) and in other capacities for the United States Marine Corps. He has B.A. from University of Arizona and an MBA from Webster University.

The founder of the firm, Mr. Walden is a prominent figure in healthcare industry mergers and acquisitions. Earlier in his career, he was associated with Phillips Appel & Walden Inc. for more than 24 years, beginning as a registered representative and eventually becoming the Chief Executive Officer and Chairman of the Board of Directors. During…

Mr. Symes is the former President and CEO of the U.S. division of Ulrich Medical, a German maker of spine, radiology and other surgical products where he grew the company 60% in three years. Prior to that he served in senior positions at Bausch & Lomb, Wyeth, Monsanto and DuPont. Mr. Symes is an expert in technology management, new product…

Carmen Mazzatta was the General Manager of several prominent healthcare companies, including Express Scripts and inVentiV Health. Mr. Mazzatta led product management, operations and innovation functions of Cardinal Health, Thompson Reuters and the Swatch Group, as well as led strategy, operations and integration projects for BSN Medical. He was a…

Steven Steiber, Ph.D. – Mr. Steiber is an experienced healthcare market research executive formerly with major companies including GfK Healthcare, Opinion Research International and the Gallup Organization. Mr. Steiber has more than 25 years experience designing market intelligence programs for leading pharmaceutical and medical device…